Dexlansoprazole Capsule, Delayed Release
Product Images NDC 72162-2214

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 72162-2214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Dexlansoprazole Delayed Release Capsules 1)

Structure (Dexlansoprazole Delayed Release Capsules 1)
Chemical structure diagram of the active ingredient Dexlansoprazole, showing its molecular framework including a substituted benzene ring, sulfoxide group, and trifluoromethoxy side chain.*
FDA Label Image

Figure 1 (Dexlansoprazole Delayed Release Capsules 2)

Figure 1 (Dexlansoprazole Delayed Release Capsules 2)
A line graph showing plasma concentration of dexlansoprazole (ng/mL) over time (hours) for two dosages: 30 mg and 60 mg. The solid line with open circles represents 60 mg, and the dashed line with open triangles represents 30 mg. Concentration peaks higher and later for the 60 mg dose compared to 30 mg, both declining to near zero by 24 hours.*
FDA Label Image

Label (Lbl721622214)

Label (Lbl721622214)
The label is for Dexlansoprazole Delayed-Release Capsules, 60 mg strength. It shows a package size of 30 capsules, is labeled for prescription use only, and includes storage instructions and a caution about FD&C Yellow No. 5. The product is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Par Formulations Private Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.